193 related articles for article (PubMed ID: 16493333)
1. [Chronic hepatitis B, advances in treatment].
Buffet C
Presse Med; 2006 Feb; 35(2 Pt 2):302-3. PubMed ID: 16493333
[No Abstract] [Full Text] [Related]
2. [Liver transplantation for complications of hepatitis B].
Roche B; Samuel D
Presse Med; 2006 Feb; 35(2 Pt 2):335-45. PubMed ID: 16493338
[TBL] [Abstract][Full Text] [Related]
3. [Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
Bourlière M
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S34-6. PubMed ID: 17075495
[No Abstract] [Full Text] [Related]
4. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
Locarnini S; Warner N
Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179
[TBL] [Abstract][Full Text] [Related]
5. Tenofovir rescue therapy in pregnant females with chronic hepatitis B.
Hu YH; Liu M; Yi W; Cao YJ; Cai HD
World J Gastroenterol; 2015 Feb; 21(8):2504-9. PubMed ID: 25741161
[TBL] [Abstract][Full Text] [Related]
6. Potential threat of drug-resistant and vaccine-escape HBV mutants to public health.
Teo CG; Locarnini SA
Antivir Ther; 2010; 15(3 Pt B):445-9. PubMed ID: 20516564
[TBL] [Abstract][Full Text] [Related]
7. [New virologic tests and their application in management of chronic hepatitis B].
Zoulim F
Presse Med; 2006 Feb; 35(2 Pt 2):317-26. PubMed ID: 16493336
[TBL] [Abstract][Full Text] [Related]
8. Studying the treatment of chronic hepatitis B viral infection in special populations.
Gish RG; Locarnini S
Methods Mol Med; 2004; 96():465-98. PubMed ID: 14762288
[No Abstract] [Full Text] [Related]
9. Chronic hepatitis B infection.
Kuo A; Gish R
Clin Liver Dis; 2012 May; 16(2):347-69. PubMed ID: 22541703
[TBL] [Abstract][Full Text] [Related]
10. Events occurring at the time of breakthrough hepatitis during lamivudine treatment for chronic hepatitis B.
Yokosuka O
J Gastroenterol; 2004 Aug; 39(8):813-4. PubMed ID: 15338383
[No Abstract] [Full Text] [Related]
11. Current therapy of chronic hepatitis B.
Pardo M; Bartolomé J; Carreño V
Arch Med Res; 2007 Aug; 38(6):661-77. PubMed ID: 17613358
[No Abstract] [Full Text] [Related]
12. Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs.
Suzuki F; Suzuki Y; Hosaka T; Sezaki H; Akuta N; Fujiyama S; Kawamura Y; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Mineta R; Suzuki Y; Kumada H
J Gastroenterol; 2017 May; 52(5):641-651. PubMed ID: 27699721
[TBL] [Abstract][Full Text] [Related]
13. High dose lamivudine and hepatitis B.
Musher DR; Wasser WG; Saggi SJ
Am J Gastroenterol; 1999 Nov; 94(11):3372. PubMed ID: 10566751
[No Abstract] [Full Text] [Related]
14. Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
Amini-Bavil-Olyaee S; Sheldon J; Lutz T; Trautwein C; Tacke F
AIDS; 2009 Jan; 23(2):268-72. PubMed ID: 19098499
[TBL] [Abstract][Full Text] [Related]
15. [Chronic hepatitis B].
Thimme R; Spangenberg HC; Blum HE
Dtsch Med Wochenschr; 2008 Jan; 133(4):135-8. PubMed ID: 18197589
[No Abstract] [Full Text] [Related]
16. Similar evolution of hepatitis B virus quasispecies in patients with incomplete adefovir response receiving tenofovir/emtricitabine combination or tenofovir monotherapy.
Lavocat F; Dény P; Pichoud C; Al Hawajri N; Kitrinos K; Borroto-Esoda K; Zoulim F
J Hepatol; 2013 Oct; 59(4):684-95. PubMed ID: 23742912
[TBL] [Abstract][Full Text] [Related]
17. [The genetic variability and clinical significance of hepatitis B virus].
Tang H; Chen EQ
Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):161-3. PubMed ID: 19554777
[No Abstract] [Full Text] [Related]
18. A hepatitis B-free generation in China: from dream to reality.
Fan R; Yin X; Liu Z; Liu Z; Lau G; Hou J
Lancet Infect Dis; 2016 Oct; 16(10):1103-1105. PubMed ID: 27676339
[No Abstract] [Full Text] [Related]
19. Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes.
Mello FC; Fernandes CA; Gomes Sde A
Mem Inst Oswaldo Cruz; 2012 May; 107(3):317-25. PubMed ID: 22510826
[TBL] [Abstract][Full Text] [Related]
20. [Natural history of hepatitis B infection].
Pol S
Presse Med; 2006 Feb; 35(2 Pt 2):308-16. PubMed ID: 16493335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]